These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17575500)
21. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma. Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106 [TBL] [Abstract][Full Text] [Related]
22. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis. Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696 [TBL] [Abstract][Full Text] [Related]
23. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958 [TBL] [Abstract][Full Text] [Related]
24. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lin P; Hsueh YM; Ko JL; Liang YF; Tsai KJ; Chen CY Lung Cancer; 2003 May; 40(2):123-9. PubMed ID: 12711112 [TBL] [Abstract][Full Text] [Related]
25. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis. Zhao HY; Gu Y; Yi YX Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529 [TBL] [Abstract][Full Text] [Related]
26. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner. Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082 [TBL] [Abstract][Full Text] [Related]
27. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. Zhang JH; Li Y; Wang R; Geddert H; Guo W; Wen DG; Chen ZF; Wei LZ; Kuang G; He M; Zhang LW; Wu ML; Wang SJ World J Gastroenterol; 2003 Jul; 9(7):1390-3. PubMed ID: 12854127 [TBL] [Abstract][Full Text] [Related]
28. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis. Gong M; Yi Q; Wang W Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485 [TBL] [Abstract][Full Text] [Related]
29. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914 [TBL] [Abstract][Full Text] [Related]
30. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. Malik MA; Zargar SA; Mittal B Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108 [TBL] [Abstract][Full Text] [Related]
31. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study. Yang S; Zhao J; Li L Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295 [TBL] [Abstract][Full Text] [Related]
32. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas. Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285 [TBL] [Abstract][Full Text] [Related]
33. Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia. Fecteau RE; Kong J; Kresak A; Brock W; Song Y; Fujioka H; Elston R; Willis JE; Lynch JP; Markowitz SD; Guda K; Chak A JAMA Oncol; 2016 Oct; 2(10):1333-1339. PubMed ID: 27467440 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697 [TBL] [Abstract][Full Text] [Related]
35. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. Malik MA; Zargar SA; Mittal B DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640 [TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Casson AG; Zheng Z; Porter GA; Guernsey DL Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856 [TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Casson AG; Zheng Z; Evans SC; Veugelers PJ; Porter GA; Guernsey DL Carcinogenesis; 2005 Sep; 26(9):1536-41. PubMed ID: 15878910 [TBL] [Abstract][Full Text] [Related]
38. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin. Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527 [TBL] [Abstract][Full Text] [Related]